Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity.
|
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
y7USzW0hCb55cR2B